Essa Pharma Inc Reports Results For The Quarter Ended December 31: Earnings Summary

ESSA Pharma

11/02/2025 14:31

* ESSA Pharma Inc  EPIX.OQ  reported a quarterly adjusted
loss
of 19 cents​​ per share for the quarter ended December 31, lower
than the same quarter last year, when the company reported EPS
of -14 cents.  The mean expectation of two analysts for the
quarter was for a loss of 18 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * ESSA Pharma Inc's reported EPS for the quarter was a loss
of 19
cents​.
    * The company reported a quarterly loss of $8.53 million.
    * ESSA Pharma Inc shares had fallen by 7.3% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for ESSA Pharma Inc
is $1.85 
This summary was machine generated from LSEG data February 11 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.18          -0.19          Missed
 Sep. 30 2024      -0.19          -0.14          Beat
 Jun. 30 2024      -0.25          -0.16          Beat
 Mar. 31 2024      -0.19          -0.20          Missed